Solid Tumor, Adult Clinical Trials in Ann Arbor, Michigan
2 recruitingAnn Arbor, Michigan
Showing 1–2 of 2 trials
Recruiting
Phase 1
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Breast CancerMetastatic Breast CancerHER2-negative Breast Cancer+4 more
Relay Therapeutics, Inc.930 enrolled37 locationsNCT05216432
Recruiting
Phase 1Phase 2
Study of DF1001 in Patients with Advanced Solid Tumors
Solid Tumor, Adult
Dragonfly Therapeutics378 enrolled52 locationsNCT04143711